University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 1045), Orange
University of California San Francisco ( Site 1044), San Francisco

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT05562830

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

UCLA Hematology/Oncology - Alhambra, Alhambra
UCLA Hematology/Oncology - Atascadero, Atascadero
UCLA Hematology/Oncology - Beverly Hills, Beverly Hills
и уште 39

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Duarte, Duarte
Providence Medical Foundation, Santa Rosa

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07277413

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT06047379

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
TRIO-US (Translational Research in Oncology-US), Los Angeles
UCLA Hematology/Oncology - Santa Monica, Los Angeles
и уште 4

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07218380

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

City of Hope Comprehensive Cancer Center, Duarte
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC San Diego Moores Cancer Center, La Jolla
и уште 1

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT06439836

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

Research Site, Los Angeles

Се регрутираФаза 2/3

Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT07815665

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

City of Hope, Duarte
START - Los Angeles, Los Angeles
Cedars Sinai, Los Angeles
и уште 1

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06293898

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

Michael G Oefelein Clinical Trials, Bakersfield
UC Irvine Health. Chao Family Comprehensive Cancer Center, Orange

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT06774131

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

University of Southern California, Los Angeles
Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
Cedars-Sanai Medical Center, Los Angeles
и уште 1

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 27.8.2026 · NCT06582017

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Research Site, Los Angeles

Се регрутираФаза 2/3

Возраст 18 и постари · Сите полови · Ажурирано 20.8.2026 · NCT07129993

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Community Cancer Institute, Clovis
USC/Norris Comprehensive Cancer Center, Los Angeles
Hoag Memorial Hospital Presbyterian, Newport Beach

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT04895709

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Los Angeles Cancer Network, Los Angeles
Pih Health Hematology Medical Oncology, Whittier

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 5.8.2026 · NCT06330064

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

Се регрутираРана фаза 1

Возраст 18 и постари · Сите полови · Ажурирано 31.7.2026 · NCT07628634

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

City of Hope, Duarte
Los Angeles Cancer Network, Glendale
California Research Institute, Los Angeles
и уште 3

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 29.7.2026 · NCT04198766

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Kaiser Permanente Anaheim Kraemer Medical Offices, Anaheim
Foothill Cardioology, Arcadia
Kaiser Permanente Baldwin Park Medical Center, Baldwin Park
и уште 58

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT04879329

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, San Francisco

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT07720284

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Urology Associates of Central California, Fresno
Urology Group of Southern California, Los Angeles
Comprehensive Urology, Los Angeles

Се регрутира

Возраст од 18 до 88 · Сите полови · Ажурирано 2.7.2026 · NCT06394869

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

USC Norris Comprehensive Cancer Center, Los Angeles

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 2.7.2026 · NCT07169734

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

University of California, Davis, Sacramento

Се регрутира

Возраст 18 и постари · Сите полови · Ажурирано 30.6.2026 · NCT06101290

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

City of Hope, Duarte
COH Lennar, Irvine

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 18.6.2026 · NCT07484022

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 30.4.2026 · NCT06682728

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

University of Southern California, Los Angeles

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 11.12.2025 · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duarte
Massive Bio SYNERGY-AI site, Irvine
Massive Bio SYNERGY-AI site, La Jolla
и уште 3

Се регрутираНабљудувачка студија

Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

University of Southern California, Los Angeles
University of California, San Francisco, San Francisco

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 9.9.2025 · NCT05107674

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Sarcoma Oncology Center, Santa Monica

Се регрутираФаза 2/3

Возраст 18 и постари · Сите полови · Ажурирано 3.4.2025 · NCT06493552

A Multicenter Cancer Biospecimen Collection Study

Curebase, San Francisco

Се регрутираНабљудувачка студија

Возраст 18 и постари · Сите полови · Ажурирано 12.3.2025 · NCT04510129

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.